-
公开(公告)号:US20090263346A1
公开(公告)日:2009-10-22
申请号:US12315876
申请日:2008-12-04
申请人: David Taft , Steven Bitler , Qiang Zheng , Stelios Tzannis , Adam Bell , Wei-Guo Dai , Sandra Ottensmann
发明人: David Taft , Steven Bitler , Qiang Zheng , Stelios Tzannis , Adam Bell , Wei-Guo Dai , Sandra Ottensmann
CPC分类号: A61K9/146 , A61K9/0019 , A61K9/0024
摘要: Systems and methods for delivering drugs. Crystalline polymeric systems, referred to as CYC carriers, are associated with the drugs, through chemical bonding or through physical association. The crystallinity of the CYC carriers results from the presence of crystallizable side chains, for example long chain n-alkyl moieties, which results in relatively low and sharp melting temperatures. One class of CYC carriers, referred to as CYSC polymers, have a majority of the crystallizable side chains pendant from the polymer backbone. Another class of CYC carriers, referred to as ECC polymers, have a majority of the crystallizable side chains attached to terminal units of the polymer backbone. The ECC polymers can for example be obtained by modification of PLGA polymers. The CYC carriers in another class are non-polymeric. Some CYC carriers, referred to as CYC assemblies, have enhanced crystallinity as a result of the physical association of crystallizable moieties which are present in different types of molecule, for example between a polymer containing crystallizable moieties and a monomer containing crystallizable moieties. Preferably the CYC carrier is bioerodable.
摘要翻译: 递送药物的系统和方法。 称为CYC载体的结晶聚合体系通过化学键合或通过物理缔合与药物相关联。 CYC载体的结晶度来自可结晶侧链的存在,例如长链正烷基部分,这导致相对低的和尖锐的熔融温度。 称为CYSC聚合物的一类CYC载体具有从聚合物主链悬挂的大部分可结晶侧链。 称为ECC聚合物的另一类CYC载体具有连接至聚合物主链末端单元的大部分可结晶侧链。 ECC聚合物可以例如通过改性PLGA聚合物获得。 另一类的CYC载体是非聚合物。 一些称为CYC组件的CYC载体由于存在于不同类型分子中的可结晶部分的物理结合而具有增强的结晶度,例如在含可结晶部分的聚合物和含可结晶部分的单体之间。 CYC载体优选是可生物侵蚀的。
-
公开(公告)号:US08399007B2
公开(公告)日:2013-03-19
申请号:US12284755
申请日:2008-09-25
申请人: David Taft , Stelios Tzannis , Wei-Guo Dai , Sandra Ottensmann , Steven Bitler , Qiang Zheng , Adam Bell
发明人: David Taft , Stelios Tzannis , Wei-Guo Dai , Sandra Ottensmann , Steven Bitler , Qiang Zheng , Adam Bell
IPC分类号: A61F2/00 , A61K31/74 , A61K31/519 , A61K31/19
CPC分类号: A61K9/146 , A61K9/0019 , A61K9/0024
摘要: Methods for making formulations of drugs and crystalline side chain polymers which formulations provide controlled and/or sustained release drug formulations.
-
公开(公告)号:US20100210792A1
公开(公告)日:2010-08-19
申请号:US12448033
申请日:2007-12-04
申请人: David Taft , Steven Bitler , Qiang Zheng , Adam Bell , Stelios Tzannis
发明人: David Taft , Steven Bitler , Qiang Zheng , Adam Bell , Stelios Tzannis
IPC分类号: A61K47/48
CPC分类号: A61K9/0024 , A61K9/0019 , A61K9/146
摘要: Formulations of drugs and crystalline side chain polymers to provide controlled and/or sustained release drug formulations.
摘要翻译: 制备药物和结晶侧链聚合物以提供受控和/或缓释药物制剂。
-
公开(公告)号:US20090209558A1
公开(公告)日:2009-08-20
申请号:US12287520
申请日:2008-10-10
申请人: David Taft , Stelios Tzannis , Wei-Guo Dai , Sandra Ottensmann , Steven Bitler , Qiang Zheng , Adam Bell
发明人: David Taft , Stelios Tzannis , Wei-Guo Dai , Sandra Ottensmann , Steven Bitler , Qiang Zheng , Adam Bell
IPC分类号: A61K31/519 , A61K31/196
CPC分类号: A61K9/146 , A61K9/1647 , A61K31/136 , A61K31/196 , A61K31/519 , A61K31/5513 , A61K47/34
摘要: Delivery of drugs in association with PLGA polymers which have crystallinity resulting from the presence of long chain alkyl groups in terminal units.
摘要翻译: 与终端单元中存在长链烷基产生结晶性的PLGA聚合物相结合的药物递送。
-
公开(公告)号:US08956602B2
公开(公告)日:2015-02-17
申请号:US11999415
申请日:2007-12-04
申请人: David Taft , Steven Bitler , Qiang Zheng , Adam Bell , Stelios Tzannis
发明人: David Taft , Steven Bitler , Qiang Zheng , Adam Bell , Stelios Tzannis
CPC分类号: A61K9/0024 , A61K9/0019 , A61K9/146
摘要: Formulations of drugs and crystalline side chain polymers to provide controlled and/or sustained release drug formulations.
摘要翻译: 制备药物和结晶侧链聚合物以提供受控和/或缓释药物制剂。
-
公开(公告)号:US08529922B2
公开(公告)日:2013-09-10
申请号:US13372510
申请日:2012-02-14
申请人: David Taft , Stelios Tzannis , Wei-Guo Dai , Sandra Ottensmann , Steven Bitler , Qiang Zheng , Adam Bell
发明人: David Taft , Stelios Tzannis , Wei-Guo Dai , Sandra Ottensmann , Steven Bitler , Qiang Zheng , Adam Bell
IPC分类号: A61K38/02 , A61K31/195 , A61K31/519 , A61K47/34 , C08G63/06 , C08G63/91
CPC分类号: A61K9/146 , A61K9/1647 , A61K31/136 , A61K31/196 , A61K31/519 , A61K31/5513 , A61K47/34
摘要: PLGA, PLA and PGA polymers which have crystallinity resulting from the presence of long chain alkyl groups in terminal units. The polymers are particularly useful for drug delivery.
摘要翻译: PLGA,PLA和PGA聚合物,其具有由末端单元中长链烷基的存在产生的结晶度。 聚合物特别适用于药物递送。
-
公开(公告)号:US20090252777A1
公开(公告)日:2009-10-08
申请号:US12284755
申请日:2008-09-25
申请人: David Taft , Stelios Tzannis , Wei-Guo Dai , Sandra Ottensmann , Steven Bitler , Qiang Zheng , Adam Bell
发明人: David Taft , Stelios Tzannis , Wei-Guo Dai , Sandra Ottensmann , Steven Bitler , Qiang Zheng , Adam Bell
CPC分类号: A61K9/146 , A61K9/0019 , A61K9/0024
摘要: Methods for making formulations of drugs and crystalline side chain polymers which formulations provide controlled and/or sustained release drug formulations.
摘要翻译: 制备药物和结晶侧链聚合物制剂的方法,其制剂提供受控和/或缓释药物制剂。
-
公开(公告)号:US20080269105A1
公开(公告)日:2008-10-30
申请号:US11999415
申请日:2007-12-04
申请人: David Taft , Steven Bitler , Qiang Zheng , Adam Bell , Stelios Tzannis
发明人: David Taft , Steven Bitler , Qiang Zheng , Adam Bell , Stelios Tzannis
IPC分类号: A61K47/32 , A61K38/02 , A61K31/136 , A61K31/519 , A61K31/5513
CPC分类号: A61K9/0024 , A61K9/0019 , A61K9/146
摘要: Formulations of drugs and crystalline side chain polymers to provide controlled and/or sustained release drug formulations.
摘要翻译: 制备药物和结晶侧链聚合物以提供受控和/或缓释药物制剂。
-
公开(公告)号:US08114883B2
公开(公告)日:2012-02-14
申请号:US12287520
申请日:2008-10-10
申请人: David Taft , Stelios Tzannis , Wei-Guo Dai , Sandra Ottensmann , Steven Bitler , Qiang Zheng , Adam Bell
发明人: David Taft , Stelios Tzannis , Wei-Guo Dai , Sandra Ottensmann , Steven Bitler , Qiang Zheng , Adam Bell
IPC分类号: A61K31/519 , A61K31/196
CPC分类号: A61K9/146 , A61K9/1647 , A61K31/136 , A61K31/196 , A61K31/519 , A61K31/5513 , A61K47/34
摘要: Delivery of drugs in association with PLGA polymers which have crystallinity resulting from the presence of long chain alkyl groups in terminal units.
摘要翻译: 与终端单元中存在长链烷基产生结晶性的PLGA聚合物相结合的药物递送。
-
公开(公告)号:US20110009571A1
公开(公告)日:2011-01-13
申请号:US12746178
申请日:2008-12-03
申请人: David Taft , Steven Bitler , Qiang Zheng , Stelios Tzannis , Adam Bell , Wei-Guo Dai , Sandra N. Ottensmann , Natarajan Balachander
发明人: David Taft , Steven Bitler , Qiang Zheng , Stelios Tzannis , Adam Bell , Wei-Guo Dai , Sandra N. Ottensmann , Natarajan Balachander
IPC分类号: C08G63/06
CPC分类号: A61K9/0024 , A61K9/0019 , A61K9/146
摘要: Systems and methods for delivering release materials, for example drugs and other bioactive materials. Crystalline polymeric systems, referred to as CYC carriers, are associated with the release materials, through chemical bonding or through physical association. The crystallinity of the CYC carriers results from the presence of crystallizable side chains, for example long chain n-alkyl moieties, which results in relatively low and sharp melting temperatures. One class of CYC carriers, referred to as CYSC polymers, have a majority of the crystallizable side chains pendant from the polymer backbone. Another class of CYC carriers referred to as ECC polymers, have a majority of the crystallizable side chains attached to terminal units of the polymer backbone. The ECC polymers can for example be obtained by modification of PLGA polymers. The CYC carriers in another class of non-polymeric. Some CYC carriers, referred to as CYC assemblies, have enhanced crystallinity as a result of the physical association of crystallizable moieties which are present in different types of molecule, for example between a polymer containing crystallizable moieties and a monomer containing crystallizable moieties. For some uses, particularly the delivery of drugs, a bioerodable CYC carrier is preferably used.
摘要翻译: 用于输送释放材料的系统和方法,例如药物和其他生物活性材料。 称为CYC载体的结晶聚合物体系通过化学键合或通过物理缔合与释放材料相关联。 CYC载体的结晶度来自可结晶侧链的存在,例如长链正烷基部分,这导致相对低的和尖锐的熔融温度。 称为CYSC聚合物的一类CYC载体具有从聚合物主链悬挂的大部分可结晶侧链。 称为ECC聚合物的另一类CYC载体具有连接至聚合物主链末端单元的大部分可结晶侧链。 ECC聚合物可以例如通过改性PLGA聚合物获得。 CYC载体在另一类非聚合物中。 一些称为CYC组件的CYC载体由于存在于不同类型分子中的可结晶部分的物理结合而具有增强的结晶度,例如在含可结晶部分的聚合物和含可结晶部分的单体之间。 对于一些用途,特别是药物的递送,优选使用生物侵蚀性CYC载体。
-
-
-
-
-
-
-
-
-